INS and type 2 diabetes mellitus: It is, thus, urgent to demonstrate scientifically the transplacental passing of sucralose, which would allow us to recommend women not to use NNS during pregnancy; above all, female patients with a T2D familial history involving a pancreatic compromise in insulin production.